ResearcherShaoxing UniversityActive in the last 2 years

Luyao Ma

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-8980-072X; OpenAlex author ID A5047873296.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

PD-1 blockade plus capecitabine as curative-intent treatment for tumor mutational burden-high multi-metastatic pancreatic ductal adenocarcinoma: A case report First author DOI 10.21203/rs.3.rs-7202690/v1 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Jinfang Xu · 1 shared paper, 2025
- Paper PD-1 blockade plus capecitabine as curative-intent treatment for tumor mutational burden-high multi-metastatic pancreat… DOI 10.21203/rs.3.rs-7202690/v1 ↗
Ketao Jin · 1 shared paper, 2025
- Paper PD-1 blockade plus capecitabine as curative-intent treatment for tumor mutational burden-high multi-metastatic pancreat… DOI 10.21203/rs.3.rs-7202690/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.